Cargando…
Structure, function and inhibition of critical protein–protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins
Mixed lineage leukemia 1 (MLL1, also known as MLL or KMT2A) is an important transcription factor and histone-H3 lysine-4 (H3K4) methyltransferase. It is a master regulator for transcription of important genes (e.g., Hox genes) for embryonic development and hematopoiesis. However, it is largely dispe...
Autores principales: | Li, Xin, Song, Yongcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022399/ https://www.ncbi.nlm.nih.gov/pubmed/33823889 http://dx.doi.org/10.1186/s13045-021-01057-7 |
Ejemplares similares
-
Theoretical models of inhibitory activity for inhibitors of protein–protein interactions: targeting menin–mixed lineage leukemia with small molecules
por: Jedwabny, Wiktoria, et al.
Publicado: (2017) -
Defining the condensate landscape of fusion oncoproteins
por: Tripathi, Swarnendu, et al.
Publicado: (2023) -
Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16
por: Ueda, Koki, et al.
Publicado: (2014) -
High-Affinity Small-Molecule
Inhibitors of the Menin-Mixed
Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein
Interaction
por: He, Shihan, et al.
Publicado: (2014) -
Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways
por: Marschalek, Rolf
Publicado: (2016)